The Limited Times

Now you can see non-English news...

Covid-19: the production capacities of laboratories pushed to the maximum

2021-01-21T20:28:28.093Z

In France, Pfizer is maintaining its target of delivering 2.6 million doses by the end of January. While the fear of a third confinement is gaining in France, pressure is mounting on pharmaceutical laboratories, and in particular on Pfizer / BioNTech, to accelerate the pace. The German-American duo's vaccine is the first to be approved in late December by Brussels, but Pfizer was forced to slow deliveries this week in Europe. The time to increase the production capacities of its Belgian factory



While the fear of a third confinement is gaining in France, pressure is mounting on pharmaceutical laboratories, and in particular on Pfizer / BioNTech, to accelerate the pace.

The German-American duo's vaccine is the first to be approved in late December by Brussels, but Pfizer was forced to slow deliveries this week in Europe.

The time to increase the production capacities of its Belgian factory in Puurs, which serves the EU and Canada in particular, has defended the laboratory.

Read also:

Does the State have too many stocks of Covid vaccines?

The announcement of this delay, which was initially to last "

three to four weeks

", had sown panic last Friday on the Old Continent.

To the point that Italy threatened Pfizer to sue it

(see page 6)…

Under pressure from Brussels, Pfizer finally promised to limit this delay to one week.

The objective of the arrangements we carry out is to optimize the entire vaccine manufacturing process: production lines, storage, loading,

This article is for subscribers only.

You have 79% left to discover.

Subscribe: 1 € the first month

Can be canceled at any time

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-01-21

You may like

News/Politics 2020-05-22T06:11:18.244Z

Trends 24h

Tech/Game 2021-02-24T14:40:40.123Z
Tech/Game 2021-02-24T13:52:23.326Z

Latest

© Communities 2019 - Privacy